Hypertension Management Dynamics in Pediatric CKD: Insights From the 4C Study

dc.authorid0000-0002-5134-8643
dc.authorid0000-0001-9073-4662
dc.contributor.authorDoyon, Anke
dc.contributor.authorBayazit, Aysun Karabay
dc.contributor.authorDuzova, Ali
dc.contributor.authorThurn, Daniela
dc.contributor.authorCanpolat, Nur
dc.contributor.authorBulut, Ipek Kaplan
dc.contributor.authorAzukaitis, Karolis
dc.date.accessioned2025-11-16T19:34:19Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBACKGROUND: Office blood pressure (BP) trajectories may help assess hypertension progression and the effects of antihypertensive treatment in children with chronic kidney disease. METHODS: Analysis of antihypertensive treatment and BP slopes in 320 patients from the 4C study (Cardiovascular Comorbidity in Children with Chronic Kidney Disease) cohort with chronic kidney disease before renal replacement therapy, based on a minimum of 3 individual observations and 2 years of follow-up. RESULTS: At enrollment, 70 (22%) patients had uncontrolled or untreated hypertension, 130 (41%) patients had controlled hypertension, and 120 (37%) patients had normotension without antihypertensive treatment. Antihypertensive treatment medication was prescribed for 53% of patients at baseline and initiated or added for 91 patients (AHT-I [group with intensification of antihypertensive treatment] group, 28%) during follow-up. Overall BP SD score remained stable over time in the cohort (beta=-0.037 +/- 0.034, P=0.34 and -0.029 +/- 0.348, P=0.093 per year for systolic and diastolic BP SD score). In the AHT-I group, systolic and diastolic BP SD scores were higher at baseline and decreased significantly during follow-up (-0.22 +/- 0.07, P<0.003 and -0.12 +/- 0.05 SD score per year, P=0.01). Only 8 of 70 (11%) patients from the previously untreated/uncontrolled group remained untreated at the last observation, while 31 (44%) were controlled during follow-up. Of the 120 normotensive patients at baseline, 60% remained normotensive while 40% progressed to uncontrolled/untreated (n=23, 19%) or controlled (n=24, 20%) hypertension. CONCLUSIONS: Although the overall BP of the population remained stable over time, individual patterns of BP management showed considerable variability. BP control improved significantly with intensified antihypertensive therapy; however, a significant number of previously normotensive individuals developed new-onset hypertension during the observation period.
dc.description.sponsorshipERA-EDTA Research Program; KfH Foundation for Preventive Medicine; German Federal Ministry of Education and Research [01EO08 02]; European Reference Network for Rare Kidney Diseases - European Union [101085068]
dc.description.sponsorshipSupport for the 4C study (Cardiovascular Comorbidity in Children with Chronic Kidney Disease) was received from the ERA-EDTA Research Program, the KfH Foundation for Preventive Medicine and the German Federal Ministry of Education and Research (01EO08 02). The study was also supported by the European Reference Network for Rare Kidney Diseases, which is funded by the European Union within the framework of the EU4Health Program (101085068).
dc.identifier.doi10.1161/HYPERTENSIONAHA.124.24330
dc.identifier.endpage1045
dc.identifier.issn0194-911X
dc.identifier.issn1524-4563
dc.identifier.issue6
dc.identifier.pmid40197029
dc.identifier.scopus2-s2.0-105002444857
dc.identifier.scopusqualityQ1
dc.identifier.startpage1035
dc.identifier.urihttps://doi.org/10.1161/HYPERTENSIONAHA.124.24330
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15313
dc.identifier.volume82
dc.identifier.wosWOS:001485547400007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofHypertension
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectantihypertensive agents
dc.subjectblood pressure
dc.subjectchild
dc.subjecthumans
dc.subjecthypertension
dc.titleHypertension Management Dynamics in Pediatric CKD: Insights From the 4C Study
dc.typeArticle

Dosyalar